What is Evolent Health, Inc.'s market cap?

Evolent Health, Inc. (EVH) has a market capitalization of $428.6M and trades on NYSE.

What is Evolent Health, Inc.'s revenue and profitability?

Evolent Health, Inc. generated $1.9B in trailing twelve-month revenue with a net loss of $496.5M, representing a net margin of -26.3%. Gross margin stands at 20.2%. These figures are based on the Q1 2026 filing.

Who are Evolent Health, Inc.'s competitors?

Evolent Health, Inc.'s key competitors include CVS Health, UnitedHealth Group, BrightSpring Health Services, Inc. Common Stock, and others. These companies compete in similar markets and product categories.

Who does Evolent Health, Inc. partner with?

Evolent Health, Inc.'s notable partners include UPMC, The Advisory Board Company, McKinsey & Company.

What subsidiaries does Evolent Health, Inc. have?

Evolent Health, Inc.'s subsidiaries include New Century Health, Machinify, Evolent Health LLC.

Where is Evolent Health, Inc. headquartered?

Evolent Health, Inc. is headquartered in United States of America and employs approximately 4,700 people. It has been publicly traded since 2015.

Evolent Health, Inc.

EVH

Evolent Health is a market leader in specialty care management, connecting health plans and risk-bearing entities with physicians to provide evidence-based care for complex conditions.

Market cap

$428.55M-63.1%

Revenue$1.9B-21.3%

Net income-$496.5M-356%

EPS (diluted)-$4.76-287%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 7, 2026

Revenue$496.2MMiss by $37.8M EPS-$0.02Beat by $0.03

Read the full report

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$597.7M

EPS estimate-$0.01

Financials

Q1 2026

Income statement

See full

Revenue$496.2M+2.6%

Gross profit$83.8M-18.2%

Operating income-$10.6M-553%

Net income-$26.6M+58.8%

EPS (diluted)-$0.24+61.9%

Balance sheet

See full

Cash & equivalents$142.0M-42.4%

Total debt$985.4M+13.3%

Total equity$396.4M-57.6%

Total assets$1.9B-29.2%

Cash flow

See full

Operating cash flow-$984.0K-122%

Valuation & ratios

Valuation

See full

Market cap$428.55M-63.1%

Enterprise value$1.27B-30.7%

P/S0.2×-0.3×

Profitability

See full

Gross margin20.2%+4.9pp

Operating margin-22.2%-23.5pp

Net margin-26.3%-33.2pp

Returns & leverage

See full

Return on equity-74.6%-90.1pp

Debt / equity2.5×+1.6×

Current ratio1.3×+0.3×

Segments

By product

See full

Performance Suite$323.3M+31.9%

Specialty Technology and Services Suite$80.8M-2.4%

Administrative Services$49.6M-13.3%

Cases$42.6M+4.8%

By segment

See full

Evolent Health Services Segment$496.2M+2.6%

Competitors

By market cap

UnitedHealth Group$379.28B+48.2%

CVS Health$136.61B+81.1%

Elevance Health$82.1B+27.4%

Cencora$60.5B+9.1%

BrightSpring Health Services, Inc.$14.1B+292%

Evolent Health, Inc.$428.6M-62.2%

Health Catalyst$158.9M-44.2%

P3 Health Partners$34.9M+52.4%

By revenue growth

BrightSpring Health Services, Inc.+28.0%

UnitedHealth Group+9.7%

Evolent Health, Inc.-21.3%

By net margin

UnitedHealth Group2.68%-2.7pp

Elevance Health2.47%-0.4pp

BrightSpring Health Services, Inc.2.27%+2.3pp

CVS Health0.719%-0.7pp

Cencora0.599%+0.6pp

Evolent Health, Inc.-26.29%-21.7pp

Health Catalyst-87.69%-64.3pp

Profile

Evolent Health is a market leader in specialty care management, connecting health plans and risk-bearing entities with physicians to provide evidence-based care for complex conditions. The company leverages proprietary technology and clinical pathways to improve patient outcomes and reduce systemic healthcare costs in high-expense areas like oncology and cardiology. Its value proposition centers on aligning financial incentives between payers and providers through an integrated, technology-enabled platform.

Competitive position

Evolent maintains a leading position by integrating clinical pathway design with proprietary workflow technology, specifically targeting the highest-cost specialty care categories.

GeographiesUnited States

Customer segmentsHealth Plans, Physician Groups, Health Systems, Governmental Payers

Business modelB2B, SaaS, Capitation, Fee-for-service, Performance-based risk sharing

SuppliersElectronic Medical Record (EMR) vendors, Pharmaceutical data providers, Cloud infrastructure providers, Clinical guideline organizations

CustomersMedicare Advantage organizations, State Medicaid agencies, Commercial insurance carriers, Self-insured employers

CountryUnited States of America

Listed2015

Employees4.7K

CEOSeth Barrie Blackley

SectorHealthcare

IndustryMedical - Healthcare Information Services

Websiteevolenthealth.com

FilingsSEC EDGAR

Ask your AI about Evolent Health, Inc..

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evolent Health, Inc.'s market cap?: Evolent Health, Inc. (EVH) has a market capitalization of $428.6M and trades on NYSE.
What is Evolent Health, Inc.'s revenue and profitability?: Evolent Health, Inc. generated $1.9B in trailing twelve-month revenue with a net loss of $496.5M, representing a net margin of -26.3%. Gross margin stands at 20.2%. These figures are based on the Q1 2026 filing.
Who are Evolent Health, Inc.'s competitors?: Evolent Health, Inc.'s key competitors include CVS Health, UnitedHealth Group, BrightSpring Health Services, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
Who does Evolent Health, Inc. partner with?: Evolent Health, Inc.'s notable partners include UPMC, The Advisory Board Company, McKinsey & Company.
What subsidiaries does Evolent Health, Inc. have?: Evolent Health, Inc.'s subsidiaries include New Century Health, Machinify, Evolent Health LLC.
Where is Evolent Health, Inc. headquartered?: Evolent Health, Inc. is headquartered in United States of America and employs approximately 4,700 people. It has been publicly traded since 2015.